Swissdamed registration is Switzerland’s mandatory database system for medical devices and IVDs, managed by Swissmedic. Starting July 1, 2026, all medical devices sold in Switzerland must be registered in the Swissdamed database before being placed on the market. This system replaces the previous EU–Swiss Mutual Recognition Agreement and creates specific Swiss regulatory requirements separate from EUDAMED registration.
What Is Swissdamed Registration and Why Do Medical Device Companies Need It?
Swissdamed registration is Switzerland’s comprehensive medical device database that tracks devices, manufacturers, and authorized representatives operating in the Swiss market. Following the breakdown of the EU–Switzerland Mutual Recognition Agreement, Swissmedic launched this independent system to maintain regulatory oversight of medical devices and IVDs sold in Switzerland.
The system operates through two main modules that mirror EUDAMED’s structure:
- Actors module: Became mandatory on August 6, 2024, requiring all Swiss-based manufacturers, authorized representatives, and importers to register and obtain identification numbers
- Devices module: Becomes mandatory on July 1, 2026, with a transition period extending until December 31, 2026, covering individual device registrations
Medical device companies need Swissdamed registration for several critical business reasons:
- Legal market access: Registration is a mandatory requirement for distributing devices in the Swiss market, with non-compliance resulting in complete market exclusion
- Regulatory compliance: The system ensures all medical devices meet Swiss regulatory standards and provides Swissmedic with comprehensive oversight capabilities
- Supply chain traceability: Registration creates complete traceability throughout the distribution network, enabling swift action during safety recalls or adverse event investigations
- Penalty avoidance: Companies that fail to register by mandatory deadlines risk losing market access and facing regulatory penalties from Swissmedic
These registration requirements establish Switzerland as a distinct regulatory territory with its own compliance framework, making Swissdamed registration essential for any company seeking to maintain or establish Swiss market presence beyond 2026.
How Does the Swissdamed Registration Process Actually Work?
The Swissdamed registration process follows a two-stage approach, starting with actor registration, followed by device registration. Companies must first register as economic operators in the Actors module before they can proceed to register individual devices in the Devices module.
The registration process involves several key steps:
- Actor registration: Manufacturers or their Swiss authorized representatives submit company information, legal documentation, and contact details through the Swissdamed portal, requiring verification and approval similar to EUDAMED’s process
- Device registration preparation: Companies compile structured data for each medical device, including Basic UDI-DI codes, risk classifications, technical specifications, and regulatory certificates
- Data submission: The system accepts XML file uploads aligned with EUDAMED’s current XSD schema, enabling bulk submissions for companies with large device portfolios
- Voluntary testing period: Manufacturers can use pre-mandatory registration periods to test submissions and resolve technical issues before deadlines
The registration timeline includes several critical milestones that companies must navigate strategically. Actor registration became mandatory in August 2024, while device registration becomes mandatory on July 1, 2026. Companies have until December 31, 2026, to complete all device registrations, except for devices subject to vigilance actions, which must be registered immediately when the Devices module becomes mandatory. This structured approach allows manufacturers to identify data quality problems and technical compatibility issues early, ensuring smoother compliance with mandatory deadlines.
What Are the Specific Requirements for Different Types of Medical Devices in Switzerland?
Swiss medical device registration requirements vary based on device classification, with each class requiring progressively more comprehensive documentation and regulatory oversight. The classification system follows the same risk-based approach used in European regulations.
Registration requirements by device class include:
- Class I devices: Require basic registration information including device identification, intended use, and manufacturer details, with complete UDI-DI information and accurate risk classification data but typically no notified body involvement
- Class IIa and IIb devices: Need additional documentation including clinical evidence, risk management files, and notified body certificates where applicable, with detailed technical specifications and demonstrated compliance with harmonized standards
- Class III devices: Face the most stringent requirements including comprehensive clinical data, detailed risk assessments, and mandatory notified body oversight, requiring complete traceability documentation and updated safety information throughout market presence
- IVDs: Follow similar classification principles but with specific requirements related to diagnostic accuracy and analytical performance data
All device classes must provide specific data elements including storage conditions, critical warnings, catalog numbers, and Essential Requirements compliance information. Manufacturers must coordinate with their notified bodies to ensure certificate registrations align with device registration timelines, particularly for higher-risk devices. These comprehensive requirements ensure that Switzerland maintains robust oversight of medical devices while providing clear pathways for manufacturers to demonstrate compliance across different risk categories.
How Much Does Swissdamed Registration Cost and How Long Does It Take?
Swissdamed registration costs start at $300 per device notification beginning in July 2026, when the Devices module becomes mandatory. Actor registration does not carry direct fees, but companies typically incur consulting costs for proper submission preparation and ongoing maintenance activities.
The total cost structure includes several components:
- Direct registration fees: $300 per device notification, with no fees for actor registration but potential approval processing costs
- Regulatory consulting support: Professional assistance for submission preparation, data validation, and compliance guidance
- Data preparation activities: Internal resource costs for standardizing device master data and preparing documentation
- Technical system integration: Specialized software solutions or XML automation capabilities for large portfolios, requiring significant upfront investment but reducing long-term maintenance expenses
Registration timelines vary significantly based on device complexity and submission approach:
- Actor registration: Can be completed within days once documentation is prepared, though approval times depend on Swiss authority workloads and submission accuracy
- Device registration: Manual entry methods may require several weeks for comprehensive portfolios, while XML automation can reduce submission time to days
- Data preparation phase: Often takes months, particularly for organizations needing to standardize device master data across multiple systems
- Technical validation: Common source of delays due to data quality issues, making early testing in sandbox environments essential
The transition period from July 1, 2026, to December 31, 2026, provides flexibility for completing registrations, but companies should begin preparations well in advance to avoid technical complications and ensure smooth compliance with mandatory deadlines.
How MedEnvoy Global Helps With Swissdamed Registration
MedEnvoy Global provides comprehensive Swissdamed registration support to help medical device manufacturers navigate Switzerland’s complex regulatory requirements efficiently and cost-effectively. Our specialized services ensure your devices achieve Swiss market access while minimizing administrative burden and compliance risks:
- Swiss Authorized Representative Services: Complete actor registration and ongoing regulatory representation throughout Switzerland
- Technical Registration Support: Expert device registration preparation, XML file optimization, and submission management
- Regulatory Compliance Guidance: Strategic advice on classification requirements, documentation standards, and timeline management
- Portfolio Management: Efficient handling of large device portfolios with automated systems and quality validation processes
Contact MedEnvoy Global today to streamline your Swissdamed registration process and secure reliable Swiss market access for your medical devices.